Considerations in perioperative assessment of valproic acid coagulopathy
- PMID: 24574585
- PMCID: PMC3927296
- DOI: 10.4103/0970-9185.125685
Considerations in perioperative assessment of valproic acid coagulopathy
Abstract
Valproic acid (VPA) is one of the widely prescribed antiepileptic drugs in children with multiple indications. VPA-induced coagulopathy may occur and constitute a pharmacological and practical challenge affecting pre-operative evaluation and management of patients receiving VPA therapy. This review summarizes the different studies documenting the incidence, severity and available recommendations related to this adverse effect.
Keywords: Adverse effects; anesthesia; coagulation disorders; perioperative care; valproic acid.
Conflict of interest statement
References
-
- Bourgeois BF. Valproic acid: Clinical use. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic Drugs. 4th ed. New York: Raven Press; 1995. pp. 633–9.
-
- Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet. 1995;29:257–86. - PubMed
-
- Gerstner T, Teich M, Bell N, Longin E, Dempfle CE, Brand J, et al. Valproate-associated coagulopathies are frequent and variable in children. Epilepsia. 2006;47:1136–43. - PubMed
-
- Serdaroglu G, Tütüncüoglu S, Kavakli K, Tekgül H. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid. J Child Neurol. 2002;17:41–3. - PubMed
-
- Raghuveer TS, Srinivasa R, Chandrasekhara MK. Valproate induced bleeding. Indian Pediatr. 1989;26:596–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
